Home/Filings/4/0000950170-24-130309
4//SEC Filing

Petras Michael B. Jr. 4

Accession 0000950170-24-130309

CIK 0001822479other

Filed

Nov 21, 7:00 PM ET

Accepted

Nov 22, 5:50 PM ET

Size

17.1 KB

Accession

0000950170-24-130309

Insider Transaction Report

Form 4
Period: 2024-11-20
Petras Michael B. Jr.
DirectorChairman & CEO
Transactions
  • Tax Payment

    Common Stock, $0.01 par value per share ("Common Stock")

    2024-11-20$13.21/sh29,250$386,393670,499 total
  • Gift

    Common Stock, $0.01 par value per share ("Common Stock")

    2024-11-2239,2435,214,337 total(indirect: By Trust)
  • Gift

    Common Stock, $0.01 par value per share ("Common Stock")

    2024-11-22+39,24339,243 total(indirect: By Trust)
Holdings
  • Stock Options

    Exercise: $17.59Exp: 2033-03-06Common Stock (404,094 underlying)
    404,094
  • Stock Options

    Exercise: $14.59Exp: 2034-03-04Common Stock (544,509 underlying)
    544,509
  • Stock Options

    Exercise: $23.00Exp: 2030-11-20Common Stock (1,118,012 underlying)
    1,118,012
  • Stock Options

    Exercise: $6.37Exp: 2032-11-07Common Stock (2,108,356 underlying)
    2,108,356
  • Stock Options

    Exercise: $20.03Exp: 2032-03-02Common Stock (478,932 underlying)
    478,932
Footnotes (9)
  • [F1]These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 65,217 Restricted Stock Units ("RSUs"), which represents 25% of the RSU award granted to the Reporting Person on November 20, 2020. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions.
  • [F2]These securities consist of 478,693 RSUs and 191,806 shares of Common Stock.
  • [F3]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose.
  • [F4]No transaction is being reported on this line. Reported on a previously filed Form 4.
  • [F5]These options were granted on March 4, 2024, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2025, subject to vesting conditions.
  • [F6]These options were granted on March 6, 2023, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2024, subject to vesting conditions.
  • [F7]These options were granted on November 7, 2022, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in three installments, as follows: 30%, 30%, and 40% of the options vest on each of the 12-month, 18-month, and 24-month anniversaries, respectively, of the date of grant, subject to the Reporting Person's continued service through each such date.
  • [F8]These options were granted on March 2, 2022, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in three equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions.
  • [F9]These options were granted on November 20, 2020, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in four equal installments on each of the first four anniversaries of the date of grant, subject to vesting conditions.

Documents

1 file

Issuer

Sotera Health Co

CIK 0001822479

Entity typeother

Related Parties

1
  • filerCIK 0001832387

Filing Metadata

Form type
4
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 5:50 PM ET
Size
17.1 KB